Fig. 6From: The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic targetGeneration of Compound 51 after modification of N-(5-alkyloxadiazol-3-yl) benzyl)-3-hydroxypyrrolidine-2-carboxamide scaffold (compound 4). The chemical structures used in the present illustration were drawn using ChemDraw Professional 21.0 softwareBack to article page